Preferred panel for diagnosing possible tick-borne disease (ie, Anaplasmosis, Ehrlichiosis, or Babesiosis) during the acute phase of the disease.
Qualitative Polymerase Chain Reaction
New York DOH Approval Status
Lavender (EDTA) or Pink (K2EDTA).
Transport 1 mL whole blood. (Min: 0.6 mL)
Serum, plasma, and heparinized specimens.
Ambient: 24 hours; Refrigerated: 1 week; Frozen: 1 week
|Yes (2008665)||Babesia Species by PCR||Refer to report|
|Yes (2007862)||Ehrlichia and Anaplasma Species by PCR||Refer to report|
Refer to individual components.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
|Component Test Code*||Component Chart Name||LOINC|
|2007863||Anaplasma phagocytophilum by PCR||30039-2|
|2007865||Ehrlichia chaffeensis by PCR||27994-3|
|2007867||Ehrlichia ewingii/canis by PCR||48865-0|
|2007869||Ehrlichia muris-like by PCR||48866-8|
|2008666||Babesia species by PCR||88233-2|
|2008668||Babesia microti by PCR||21089-8|